Jazz Pharmaceuticals PLC at Jefferies London Healthcare Conference Transcript
Good afternoon, everyone, day 1 London Healthcare Conference. Very factoring, we should have done a bigger room. Jazz is a hot ticket for sure. For those who don't know me, my name is Akash Tewari. I'm a pharma biotech analyst here at Jefferies, and I have the pleasure of hosting the Jazz Pharmaceuticals management team. Joining me today, and they will be giving some brief introductory remarks will be Renee Gala, President, Kelvin Tan, Chief Medical Officer; and then Samantha Pearce, Head of Europe and International. I'll give it -- I'll hand it over to you for some introductory remarks and we'll get started.
Sure. Yes. Okay. So just a reminder, we will be making forward-looking statements today. Please see our website and SEC filings for more information about our business. Should we refer to guidance, we're not updating or reiterating today. This is as of our earnings call last week. And then finally, should we refer to non-GAAP
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |